Cansino Biologics Inc. (688185.SH) disclosed its 2025 A-share restricted stock incentive plan (draft), proposing to grant 2.58 million restricted shares to eligible participants, representing approximately 1.04% of the company's total share capital at the time of the 2025 A-share incentive plan draft announcement. The initial grant will comprise 2.0655 million shares to a total of 87 eligible participants, with a grant price (including reserved shares) set at 41.20 yuan per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments